| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.918 | 4.965 | 8.401 | 7.999 | 9.249 | 83.214 | 226.575 | 187.952 | 161.815 | 163.580 |
| Total Income - EUR | 3.955 | 4.997 | 8.403 | 8.199 | 9.292 | 83.231 | 226.575 | 187.954 | 161.815 | 165.528 |
| Total Expenses - EUR | 8.593 | 11.718 | 3.607 | 4.103 | 5.821 | 13.177 | 15.733 | 14.428 | 19.994 | 32.034 |
| Gross Profit/Loss - EUR | -4.637 | -6.721 | 4.797 | 4.095 | 3.471 | 70.054 | 210.842 | 173.525 | 141.821 | 133.493 |
| Net Profit/Loss - EUR | -4.755 | -6.870 | 4.545 | 3.851 | 3.271 | 69.257 | 208.652 | 171.684 | 140.235 | 128.627 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Damis Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.501 | 0 | 0 | 0 | 614 | 567 | 337 | 338 | 2.980 | 23.823 |
| Current Assets | 32.388 | 29.703 | 27.484 | 23.052 | 22.447 | 71.357 | 209.895 | 172.730 | 138.851 | 128.013 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.851 | 223 | 142 | 140 | 137 | 23.066 | 125.860 | 134.220 | 109.426 | 93.626 |
| Cash | 9.687 | 10.822 | 9.000 | 4.907 | 4.653 | 48.291 | 84.035 | 38.510 | 29.424 | 34.387 |
| Shareholders Funds | 36.865 | 29.619 | 27.210 | 22.645 | 21.040 | 69.306 | 208.701 | 171.733 | 140.284 | 128.675 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24 | 84 | 276 | 407 | 2.022 | 2.617 | 1.531 | 1.335 | 1.546 | 24.038 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Damis Med Srl